GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Syngen Biotech Co Ltd (ROCO:8279) » Definitions » Construction In Progress

Syngen Biotech Co (ROCO:8279) Construction In Progress : NT$23 Mil (As of Jun. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Syngen Biotech Co Construction In Progress?

Syngen Biotech Co's quarterly construction in progress declined from Dec. 2023 (NT$46 Mil) to Mar. 2024 (NT$33 Mil) and declined from Mar. 2024 (NT$33 Mil) to Jun. 2024 (NT$23 Mil).

Syngen Biotech Co's annual construction in progress increased from Dec. 2021 (NT$8 Mil) to Dec. 2022 (NT$33 Mil) and increased from Dec. 2022 (NT$33 Mil) to Dec. 2023 (NT$46 Mil).


Syngen Biotech Co Construction In Progress Historical Data

The historical data trend for Syngen Biotech Co's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Syngen Biotech Co Construction In Progress Chart

Syngen Biotech Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Construction In Progress
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 13.46 8.41 32.74 45.81

Syngen Biotech Co Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Construction In Progress Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 39.75 39.96 45.81 33.46 22.92

Syngen Biotech Co Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.


Syngen Biotech Co Business Description

Traded in Other Exchanges
N/A
Address
Building A, NO.154, Kai-Yuan Road, Xinying District, Tainan, TWN, 73055
Syngen Biotech Co Ltd is a biotechnology company. It is engaged in the manufacturing, sales, and trading of microbial pharmaceutical raw materials. It also provides the design and development of health food and biochemical nutrition. The company's products include pharmaceutical ingredients, nutritional ingredients, biology fermentation products, biology agriculture and aquaculture products.

Syngen Biotech Co Headlines

No Headlines